EP3616695
Seftólósan/tasóbaktam til notkunar við meðhöndlun á sýkingum í lungum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.9.2012EP published:
23.10.2024EP application number:
19203616.8
EP translation filed:
28.11.2024Grant published:
15.12.2024EPO information:
European Patent Register
Max expiry date:
6.9.2032Expiry date:
6.9.2026Next due date:
30.9.2026
Title in English:
CEFTOLOZANE/TAZOBACTAM FOR TREATING INTRAPULMONARY INFECTIONSLanguage of the patent:
English
Timeline
Today
7.9.2012EP application
23.10.2024EP Publication
28.11.2024Translation submitted
15.12.2024Registration published
6.9.2026Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
CHANDORKAR, Gurudatt, A.Address:
Waltham, MA Massachusetts 02452, US
Name:
HUNTINGTON, Jennifer, A.Address:
Reading, MA Massachusetts 01867, US
Name:
PARSONS, TaraAddress:
Hanover, MA Massachusetts 02339, US
Name:
UMEH, Obiamiwe, C.Address:
Acton, MA Massachusetts 01720, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161532914 PDate:
9.9.2011Country:
US
Number:
201261657386 PDate:
8.6.2012Country:
US
Classification
Categories:
A61K 31/397, A61K 9/00, A61K 31/431, A61K 31/546, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 10.9.2025
Expires: 6.9.2026
Payer: Árnason Faktor ehf.